Delivery Order SPE2DB24D2100-SPE2DB25FBFUQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,032.44 to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine Vials. This firm fixed price contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a routine medical supply procurement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major...
- The Defense Logistics Agency awarded a Delivery Order valued at $4,315.56 to AmerisourceBergen Drug Corp for IMOVAX Rabies Vaccine Vials, with a firm fixed price contract type. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025. This delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract reflects DLA's ongoing pharmaceutical procurement needs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,113.75 firm fixed-price delivery order is for IMOVAX Rabies Vaccine Vials and has a completion date of March 20, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of IMOVAX Rabies Vaccine Vials with a ceiling value of $12,591.13 under a firm fixed-price contract type. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. This award was made without a set-aside designation, indicating it was competitively awarded. The delivery order...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMOVAX Rabies Vaccine vials. The contract has a ceiling value of $1,079.35 and a completion date of September 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty medications, vaccines, and medical supplies, to support military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,682.50 to AmerisourceBergen Drug Corp for Imovax Rabies Vaccine Vials, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order, awarded on August 19, 2025, represents a non-competitive award under an existing contract vehicle. The vaccine will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting federal medical supply requirements, particularly for...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMOVAX rabies vaccine vials. The contract has a ceiling value of $1,942.83 and a period of performance through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. In addition to this delivery order, Amerisourcebergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,808.96 firm fixed-price contract is for the procurement of IMOVAX Rabies Vaccine Vials, with a completion date of June 26, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,227.50 delivery order for IMOVAX Rabies Vaccine vials under a firm fixed-price contract type. This non-set-aside award was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,158.70 firm-fixed price delivery order is for the supply of IMOVAX Rabies Vaccine vials. The contract has an ultimate completion date of May 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as the primary...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFUQDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for the supply of IMOVAX Rabies Vaccine vials, with a contract ceiling value of $3,118.50. The award, issued on August 13, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded through the federal procurement process. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies vaccines, medications, and medical supplies to support military healthcare systems and the Defense Health Agency. The rabies vaccine procurement reflects the company's ongoing role in fulfilling specialized pharmaceutical and medical supply requirements across the federal government's healthcare procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/13/25 |